CD40LG and congenital toxoplasmosis: Building on this, a recent multicenter trial validated a monthly gestational screening paradigm using point-of-care ICT, which accurately identified acute maternal infections, reduced false-positive IgM results, and facilitated rapid initiation of treatment to prevent congenital toxoplasmosis [71].